British Journal of Pharmacology

Cover image for Vol. 171 Issue 9

Editor-in-Chief: Professor J.C. (Ian) McGrath

Impact Factor: 5.067

ISI Journal Citation Reports © Ranking: 2012: 21/261 (Pharmacology & Pharmacy)

Online ISSN: 1476-5381

Associated Title(s): British Journal of Clinical Pharmacology


BJP is a journal of The British Pharmacological Society

Aims and Scope

The British Journal of Pharmacology is a broad-based journal giving leading international coverage of all aspects of experimental pharmacology. It publishes high quality original research, and authoritative reviews and commentaries. Each year a range of themed issues are published and a must-read supplement, the Guide to Receptors and Channels (GRAC) is published every other year.

Effective with the 2013 volume, this journal will be published in an online-only format. Issues of this title will be published online only and will not be printed but authors will still be able to order offprints of their own articles.


Pharmacologists; toxicologists; pharmaceutical researchers; medicinal chemists; molecular biologists; physiologists; neuroscientists; target discovery and drug discovery researchers, pharmacists; clinicians.


British Journal of Pharmacology, BJP, journal, pharmacology, pharmacological, drugs, therapeutics, medicinal chemistry, pharmaceutical medicine, experimental pharmacology, translational research, biopharmaceuticals, drug discovery, drug safety, pharmacokinetics & drug metabolism, toxicology, neuropharmacology, cardiovascular pharmacology, respiratory pharmacology, immunopharmacology, cancer, endocrine pharmacology, GRAC, receptors, channels, transporters, G-protein coupled receptors, antagonist, agonist, drug targets, target discovery, drug design, pharma, pharmaceutical research, British Pharmacological Society.

Abstracting and Indexing Information

  • BIOBASE: Current Awareness in Biological Sciences (Elsevier)
  • BIOSIS (Thomson Reuters)
  • Index Medicus/MEDLINE (NLM)
  • MEDLINE/PubMed (NLM)
  • Research Alert (Thomson Reuters)